KR20000067187A - Cosmetics containing Paeonia Suffruticosa Andrews extracts - Google Patents
Cosmetics containing Paeonia Suffruticosa Andrews extracts Download PDFInfo
- Publication number
- KR20000067187A KR20000067187A KR1019990014768A KR19990014768A KR20000067187A KR 20000067187 A KR20000067187 A KR 20000067187A KR 1019990014768 A KR1019990014768 A KR 1019990014768A KR 19990014768 A KR19990014768 A KR 19990014768A KR 20000067187 A KR20000067187 A KR 20000067187A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- bark
- skin
- cosmetic composition
- solvent
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 79
- 239000002537 cosmetic Substances 0.000 title claims abstract description 30
- 240000005001 Paeonia suffruticosa Species 0.000 title claims 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 title claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims abstract description 27
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000000203 mixture Substances 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 238000001816 cooling Methods 0.000 claims abstract description 14
- 239000002904 solvent Substances 0.000 claims abstract description 13
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 11
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims abstract description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000011187 glycerol Nutrition 0.000 claims abstract description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 7
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 5
- 238000001704 evaporation Methods 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 claims 1
- 239000012046 mixed solvent Substances 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 9
- 239000004480 active ingredient Substances 0.000 abstract description 2
- 238000001035 drying Methods 0.000 abstract description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- 150000002334 glycols Chemical class 0.000 abstract 1
- 238000000935 solvent evaporation Methods 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 31
- 239000000243 solution Substances 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 230000000694 effects Effects 0.000 description 13
- 230000002401 inhibitory effect Effects 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 12
- 230000009759 skin aging Effects 0.000 description 12
- 230000003078 antioxidant effect Effects 0.000 description 11
- 230000002087 whitening effect Effects 0.000 description 10
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 229920002674 hyaluronan Polymers 0.000 description 9
- 229960003160 hyaluronic acid Drugs 0.000 description 9
- 230000007760 free radical scavenging Effects 0.000 description 8
- 230000005764 inhibitory process Effects 0.000 description 8
- 239000000049 pigment Substances 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- 230000037394 skin elasticity Effects 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000016387 Pancreatic elastase Human genes 0.000 description 7
- 108010067372 Pancreatic elastase Proteins 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 7
- 229910052760 oxygen Inorganic materials 0.000 description 7
- 239000001301 oxygen Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 235000013599 spices Nutrition 0.000 description 6
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- 239000004744 fabric Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 4
- 108010014258 Elastin Proteins 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 235000013871 bee wax Nutrition 0.000 description 4
- 239000012166 beeswax Substances 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229920002549 elastin Polymers 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 229930014626 natural product Natural products 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 150000003626 triacylglycerols Chemical class 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000002849 elastaseinhibitory effect Effects 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 3
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 3
- 229940113124 polysorbate 60 Drugs 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical group [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 2
- IVSPJKRLTWBHHN-UHFFFAOYSA-N 1-sulfanyloxybutane Chemical compound CCCCOS IVSPJKRLTWBHHN-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- YRMDSRNHSJVMLK-UHFFFAOYSA-N dodecyl methyl sulfate Chemical compound CCCCCCCCCCCCOS(=O)(=O)OC YRMDSRNHSJVMLK-UHFFFAOYSA-N 0.000 description 2
- 230000002431 foraging effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- 230000003061 melanogenesis Effects 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 102100022712 Alpha-1-antitrypsin Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 208000001382 Experimental Melanoma Diseases 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 101000823116 Homo sapiens Alpha-1-antitrypsin Proteins 0.000 description 1
- 101001010513 Homo sapiens Leukocyte elastase inhibitor Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-QIUUJYRFSA-N beta-D-glucuronic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-QIUUJYRFSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229920002055 compound 48/80 Polymers 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 목단피 추출물을 함유하는 화장료 조성물에 관한 것으로서, 목단피를 완전건조한 후 건조중량에 대하여 추출 용매로서 물, 에탄올, 메탄올, 프로판올, 부탄올, 아세톤, 에틸아세테이트, 헥산, 벤젠, 클로로포름, 글리세린, 에틸렌글리콜 및 프로필렌글리콜로 구성된 그룹으로부터 선택된 하나이상의 용매를 사용하여, 냉각 콘덴서가 장치되어 용매가 증발되는 것을 방지한 상태에서 50-95℃, 4-20시간 가열하여 추출하거나 5-37℃에서 1-15일간 침적시켜 유효성분을 추출한 후, 용매를 회수한 후, 그 건조중량으로서 0.001-10%, 바람직하게는 0.001-5%의 양으로 화장료에 첨가한 것을 특징으로 하는 것이다.The present invention relates to a cosmetic composition containing a extract of bark skin, and after drying the bark skin, water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, benzene, chloroform, glycerin, ethylene Using one or more solvents selected from the group consisting of glycols and propylene glycol, extraction is carried out by heating at 50-95 ° C. for 4-20 hours with a cooling condenser installed to prevent solvent evaporation or 1- at 5-37 ° C. After immersing for 15 days to extract the active ingredient, the solvent was recovered, and then added to the cosmetic in an amount of 0.001-10%, preferably 0.001-5%, as its dry weight.
Description
본 발명은 목단피로부터 추출된, 프리라디칼 소거작용, 항산화작용 및 미백효과를 갖는 추출물 및 이 추출물을 함유하는 화장료에 관한 것이다.The present invention relates to extracts having free radical scavenging activity, antioxidant activity and whitening effect extracted from bark skin and cosmetics containing the extract.
피부노화 메카니즘은 다음과 같다. 자외선이나 외부환경적 요인에 의해 활성산소나 프리라디칼이 생성 되며, 생성된 활성산소나, 프리라디칼에 의해 세포막이 공격을 당하게 되어 피부는 염증(inflammation)이 일어나며, 염증화된(inflammated) 조직은 생리학적 진행 메카니즘에 의해 단백질이나 유전자 물질 등을 파괴 하여 주름 등을 형성하는 피부노화가 일어난다. 피부노화 메카니즘에 관여 되는 단계를 모두 억제, 막아 주는 것이 피부노화를 근본적으로 줄여 줄 수 있다.The skin aging mechanism is as follows. Free radicals or free radicals are produced by ultraviolet rays or external environmental factors. Cell membranes are attacked by the generated free radicals or free radicals, and the skin is inflammated. Inflammated tissues The aging process leads to skin aging that destroys proteins and genetic material and forms wrinkles. Inhibiting and preventing all steps involved in the skin aging mechanism can fundamentally reduce skin aging.
상기의 작용을 상세히 설명하면 다음과 같다. 활성산소 억제에 대해서 상세히 설명하면, 일반적으로 공기 중에 산소가 없으면 생물은 존재해지 않는다. 그러나 산소는 자외선이나 효소 등의 영향을 받으면 활성산소가 된다. 이 활성산소는 지방산을 산화시켜 과산화물을 생성시킨다. 생체의 생체막 인지질도 산화시켜 장해를 일으킨다. 생성된 과산화물과 활성산소는 유전자 손상을 일으켜 노화를 촉진시킨다. 이 활성산소는 티로신에서 멜라닌을 생성하는 기구에도 영향을 일으켜 피부의 흑화에도 관여한다. 이 활성산소를 억제하는 것은 피부노화 화장료에 중요한 요소이다. 화장품, 의약품, 식품에 첨가되는, 활성산소 억제와 항산화 효과가 있는, 화학물질이 알려져 있다. 그러나, 이러한 화학물질들은 장기간 인간의 피부에 적용할 경우에 안전성에 문제가 있으므로 사용이 제한된다. 천연물은 활성산소 억제 효과가 약한 것이 대부분이지만 사람의 피부에 대해서는 안전성이 보증된다. 따라서, 활성산소 억제 효과 및 항산화 효과가 강하고 사람의 피부에 대해서도 안전성이 있는 물질이 요구되고 있다.The above operation is described in detail as follows. Regarding the inhibition of free radicals, in general, there is no organism in the absence of oxygen in the air. However, oxygen becomes free radicals under the influence of ultraviolet rays or enzymes. This active oxygen oxidizes fatty acids to produce peroxides. Biological membrane phospholipids of living organisms are also oxidized and cause disorders. The generated peroxides and free radicals cause gene damage that promotes aging. This active oxygen also affects the mechanisms that produce melanin in tyrosine and is also involved in skin blackening. Inhibiting this active oxygen is an important factor for skin aging cosmetics. Chemicals, which are added to cosmetics, medicines, and foods, have an active oxygen inhibitory and antioxidant effect. However, these chemicals are limited in their safety when applied to human skin for a long time. Natural products are mostly weak in inhibiting free radicals, but the safety of human skin is guaranteed. Therefore, there is a demand for a substance having a strong active oxygen inhibitory effect and an antioxidant effect and having a safety against human skin.
또, 피부에서 엘라스틱 섬유는 콜라겐 섬유와 더불어 진피(epiderm)안쪽에서 가교 결합을 형성한다. 나이가 들어감에 따라 지속적인 자외선 노출이나 피부의 염증 반응 등과 같은 여러 가지 요인에 의해 섬유 아세포로부터 엘라스틴 분해 효소인 엘라스타제 분비작용으로 피부의 탄력이 급격히 저하되고, 함몰(sagging)이 생긴다. 조직학적으로는 염증 세포의 침윤이 증가하며, 엘라스틴 섬유의 결핍과 응집, 콜라겐 섬유의 감소를 보여주며, 생화학적으로는 엘라스타제의 활성도가 현격히 증가한다. 엘라스타제는 엘라스틴을 분해 할 수 있는 지금까지 알려진 유일한 효소이며, 이에 대한 저해는 피부 노화를 근본적으로 줄여 줄 수 있다. 피부 노화를 지연시키기 위하여 종래에는 보습제, 항염증제, 엘라스틴 및 콜라겐 가교 결합이 파괴되어 있는 조직에 영양 및 첨가제 등을 화장료에 배합하는 방법이 이용되고 있는데, 이는 근본적으로 노화를 지연시키는데는 한계가 있는 실정이다. 따라서 피부 탄력을 유지 시키는 엘라스틴 및 콜라겐의 분해를 근본적으로 저해시키는 저해제가 요구되고 있는 실정이다.In the skin, the elastic fibers together with the collagen fibers form crosslinks inside the dermis. As you age, the elasticity of the elastinase, an elastin-degrading enzyme, is released from fibroblasts and causes a sudden decrease in skin elasticity and sagging due to various factors such as continuous UV exposure or skin inflammatory response. Histologically, the infiltration of inflammatory cells is increased, the deficiency and aggregation of elastin fibers, and the reduction of collagen fibers are shown. Biochemically, the activity of elastase is significantly increased. Elastase is the only enzyme known so far to break down elastin, and its inhibition can fundamentally reduce skin aging. In order to delay skin aging, a method of combining nutrition and additives with cosmetics in tissues in which moisturizers, anti-inflammatory agents, elastin and collagen cross-links are broken is used, which is fundamentally limited in delaying aging. to be. Therefore, there is a need for inhibitors that fundamentally inhibit the degradation of elastin and collagen to maintain skin elasticity.
종래의 노화 방지 효과를 갖는 원료가 근본적으로 노화를 저해하지 못하는 단점으로 인하여 새로운 기능성 물질들을 찾고자 하는 연구가 시도되어 왔다. 종래부터 생약등으로 사용되어 오던 여러 가지 자연의 천연물등은 안정성이 뛰어 날뿐 아니라 여러 가지 유익한 약효성분등을 함유하고 있어 좋은 검색대상이 되어 오고 있다.Due to the disadvantage that the raw material having a conventional anti-aging effect does not fundamentally inhibit aging, research has been attempted to find new functional materials. Various natural natural products, which have been used as herbal medicines for a long time, have not only excellent stability, but also contain various beneficial drug substances and have been a good search target.
히아루론라제 작용에 대해서 상세히 설명 하면, 히아루론라제는 생체중에 넓게 분포하며, 피부에도 존재하는 효소이며, 히아루론산을 분해한다. 히아루론산은 β-D-N-acetylglucosamine 과 β-D-glucouronic acid이 교차로 결합된 직쇄상의 고분자 다당이며, 글루코 아미노 글루칸(GAG)의 일종이다. 결합 조직내의 히아루론산의 작용으로는 세포가 수분을 보유하며, 조직내의 메트릭스를 형성하여 세포가 수분을 보유하게 된다. 히아루론산은 나이가 먹음에 따라 감소하고, 그 결과 수분 보유능이 저하되어 노화를 일으킨다. 따라서 히아루론산을 분해하는 히아루론라제의 활성을 억제 하는 것은 제재에 사용 되고 있는 히아루론산의 안정성이나 피부에 도포한 후의 제형에서의 히아루론산 및 피부에 존재하는 히아루론산의 안정성에 기여한다.When explaining the action of hyaluronicase in detail, hyaluronicase is widely distributed in the living body, an enzyme also present in the skin, and decomposes hyaluronic acid. Hyaluronic acid is a straight chain polysaccharide with a crosslink of β-D-N-acetylglucosamine and β-D-glucouronic acid, a type of glucosamino glucan (GAG). In the action of hyaluronic acid in the connective tissue, the cells retain moisture, and the matrix forms within the tissue, thereby retaining the moisture. Hyaluronic acid decreases with age, and as a result, water retention decreases, causing aging. Therefore, inhibiting the activity of hyaluronic acid that decomposes hyaluronic acid contributes to the stability of hyaluronic acid used in the preparation and to the stability of hyaluronic acid and hyaluronic acid present in the skin in the formulation after application to the skin.
미백 작용을 상세히 설명하면 다음과 같다. 피부는 여러 가지 중요한 기능을 가지고 있다. 그 중에서도 대표적인 것은 태양광의 자외선으로부터 신체를 보호하기 위하여 멜라닌 생성을 억제하는 기능이다. 멜라닌은 피부 세포의 일종인 멜라노사이트에서 생성되고, 피부 표면에 분포되어 인체에 유해한 자외선을 차단하는 자연적인 스크리닝을 가지고 있다. 멜라닌 생성 기저에는 멜라노사이트에서 합성되는 티로시나제라는 효소가 있다. 티로시나제는 티로신이라는 아미노산을 기질로 하여 도파(DOPA)를 거쳐 도파퀴논(Dopaquinone)을 생성시키며, 도파퀴논으로부터 여러 단계의 산화 축합 반응으로 흑색색소인 멜라닌이 생성된다. 이미 아스코르빈산(특개평 4-9320), 하이드로퀴논(특개평 6-192062), 코지산(특개 56-7710), 알부틴(특개평 4-9315) 및 일부의 추출물등이 티로시나제 저해 활성을 가지고 있어 미백 화장료로 이용되고 있으나, 처방계 중에서의 안정성이 나빠 분해되어 착색되거나, 이취의 발생, 생체 레벨에서의 효능, 효과의 불분명 및 안전성 문제 등으로 그 사용이 제한되고 있는 실정이다. 그리고 티로시나제의 억제 효과는 입증되었으나, 실제 생체 레벨과 유사한 실험에서는 그 효과가 낮게 나타난다. 따라서 생체레벨과 유사한 멜라노마 세포 배양에 의한 저해 효과가 요구되고 있는 실정이다. 또한 하이드로퀴논은 발암성 물질로 규정되어 사용이 금지되고 있다. 코지산과 아스코르빈산은 매우 불안정한 물질이다. 소량 함유한 화장료를 실온에서 수주일동간 보관하면 갈변 현상이 발생한다. 알부틴도 세포 독성을 일으키는 등 안전성 문제가 지적되고 있다. 반면, 천연물들은 안전성이 뛰어날 뿐만 아니라 여러 가지 유익한 성분들을 가지고 있어 미백 물질의 좋은 검색대상이 되고 있다.The whitening action is described in detail as follows. Skin has many important functions. Representative among them is a function of suppressing melanin production in order to protect the body from ultraviolet rays of sunlight. Melanin is produced from melanocytes, a kind of skin cells, and has a natural screening that is distributed on the surface of the skin and blocks ultraviolet rays harmful to the human body. Underlying melanogenesis is an enzyme called tyrosinase that is synthesized in melanocytes. Tyrosinase generates dopaquinone via dopa (DOPA) based on an amino acid called tyrosine, and melanin, which is a black pigment, is produced by several stages of oxidative condensation reaction from dopaquinone. Ascorbic acid (JP-A 4-9320), hydroquinone (JP-A 6-192062), kojic acid (JP-A 56-7710), arbutin (JP-A 4-9315) and some extracts have tyrosinase inhibitory activity. Although it is used as a whitening cosmetic, the stability in the prescription system is poorly degraded and colored, or its use is limited due to the occurrence of off-flavor, efficacy at the biological level, unclear effect and safety problems. And the inhibitory effect of tyrosinase has been demonstrated, but the effect is low in experiments similar to the actual biologic level. Therefore, the inhibitory effect of the melanoma cell culture similar to the biological level is required. Hydroquinone is also regulated as a carcinogenic substance and is prohibited from use. Kojic acid and ascorbic acid are very unstable substances. Browning may occur when a small amount of cosmetics are stored at room temperature for several weeks. Arbutin also causes cytotoxicity and safety issues have been pointed out. On the other hand, natural products are not only safe but also have various beneficial ingredients, making them a good target for whitening substances.
종래부터 피부노화의 억제기능을 가진 원료가 갖는 문제점을 해결하기 위해서 한방제로 사용되고 있는 생약, 야채, 과일, 꽃 등의 안전성이 뛰어난 식물추출물로부터 피부노화를 근본적으로 억제할 수 있는 여러 가지 효과를 가진 추출물을 찾고자 하는 노력이 있어 왔다.In order to solve the problems of raw materials having the function of suppressing skin aging, it has various effects that can fundamentally suppress skin aging from plant extracts having excellent safety, such as herbal medicines, vegetables, fruits and flowers, which are used as herbal medicines. Efforts have been made to find extracts.
따라서, 본 발명의 목적은, 우수한 프리라디칼 소거작용, 항산화 작용, 미백 작용 등의 효능이 우수하고 안정성에 문제가 없는 천연물 추출물을 제공하는 것이다.Accordingly, it is an object of the present invention to provide a natural product extract that is excellent in efficacy, such as excellent free radical scavenging action, antioxidant action, whitening action and the like, without any problems in stability.
본 발명의 다른 목적은 이러한 효능을 갖는 추출물을 포함하는 화장료 조성물을 제공하는 것이다.Another object of the present invention is to provide a cosmetic composition comprising an extract having such efficacy.
상기의 본 발명의 목적은 목단피 추출물 및 그 목단피 추출물을 함유하는 화장료 조성물에 의해 달성된다.The above object of the present invention is achieved by a cosmetic composition containing the extract of the bark and its extract.
본 발명의 발명자들은, 피부노화 방지에 근본적으로 기여하는 물질을 찾고자 자연의 여러 가지 천연물질들 중에서 노화예방에 유효한 물질을 검색한 결과, 목단피로부터 추출한 추출물이 항엘라스타제 및 항히아루론라제 효과를 가짐으로 인해 피부노화를 근본적으로 막을 수 있고, 매우 우수한 프리라디칼 소거작용, 항산화작용 및 미백효과등의 효능을 나타냄을 발견하였으며 안정성에도 문제가 없음을 발견하였다.The inventors of the present invention, in search of a substance that is effective in preventing aging among various natural substances in nature in order to find a substance that contributes fundamentally to the prevention of skin aging, the extract extracted from the bark skin has an anti-elastase and anti-hyaluronase effect It has been found to be able to fundamentally prevent skin aging and to exhibit very good free radical scavenging effect, antioxidant activity and whitening effect and no problem in stability.
또한 화장료 조성물에 목단피 추출물을 일정농도 이상 배합하여 사람 피부에 직접 도포한 실험 결과에서도 뚜렷한 피부 탄력 및 노화로 기인한 피부상태가 개선되는 효과를 발휘하게 됨을 발견하게 되었다.In addition, it was found that the skin condition due to distinct skin elasticity and aging is improved even in the experimental results of directly applying the extract of the bark skin to the cosmetic composition at a certain concentration.
본 발명의 목단피 추출방법은 다음과 같다.The extract of the neck bark of the present invention is as follows.
일차로 목단피를 완전건조한 후 건조중량에 대하여 추출 용매로서 물, 에탄올, 메탄올, 프로판올, 부탄올, 아세톤, 에틸아세테이트, 헥산, 벤젠, 클로로포름, 글리세린, 에틸렌글리콜 및 프로필렌글리콜로 구성된 그룹으로부터 선택된 하나이상의 용매를 1-20배 부피량을 가한다. 추출 방법으로는 냉각 콘덴서가 장치되어 용매가 증발되는 것을 방지한 상태에서 50-95℃, 4-20시간 가열하여 추출하거나 5-37℃에서 1-15일간 침적시켜 유효성분을 추출하는 방법을 사용할수 있다. 이렇게 추출한 목단피 추출물을 냉각 콘덴서가 달린 증류장치를 이용하여 증발되어 나오는 용매를 회수하면서 완전히 감압 농축한 후 그 건조중량으로서 0.001-10%, 바람직하게는 0.001-5%의 양으로 화장료에 첨가하는 것이다.At least one solvent selected from the group consisting of water, ethanol, methanol, propanol, butanol, acetone, ethyl acetate, hexane, benzene, chloroform, glycerin, ethylene glycol and propylene glycol as extraction solvents for dry weight after primary drying Add 1-20 times by volume. Extraction method is a method of extracting by heating at 50-95 ° C for 4-20 hours or extracting active ingredient at 5-37 ° C for 1-15 days while cooling condenser is installed to prevent evaporation of solvent. Can be. The extracted bark bark extract is concentrated under reduced pressure while recovering the solvent evaporated using a distillation apparatus equipped with a cooling condenser, and then added to the cosmetic powder in an amount of 0.001-10%, preferably 0.001-5% as its dry weight. .
이하 실시예에 의해 본 발명을 상세하게 설명한다.The present invention will be described in detail with reference to the following Examples.
아래의 실시예 및 실험 예는 본 발명의 내용을 설명하기 위한 것이며, 본 발명의 내용이 여기에 한정되지는 않는다.The following Examples and Experimental Examples are for explaining the content of the present invention, but the content of the present invention is not limited thereto.
실시예 1.Example 1.
완전 건조시킨 목단피 1kg 물 20kg에 넣고 냉각 콘덴서가 달린 추출기에서 5시간 끓여서 추출한 후 400 메쉬 여과포로 여과하고 상온으로 냉각한 후 5-15℃에서 7일간 방치하여 숙성시킨 후 와트만 2번 여과지로 여과 하였다. 이 추출물을 냉각 콘덴서가 달린 증류장치에서 60℃로 감압 농축하여 105g(건조중량)을 얻었다.1kg of dried dried bark skin was added to 20kg of water and boiled for 5 hours in an extractor equipped with a cooling condenser. The mixture was filtered through a 400 mesh filter cloth, cooled to room temperature, left to mature at 5-15 ° C for 7 days, and then filtered through Whatman 2 filter paper. It was. The extract was concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser to obtain 105 g (dry weight).
실시예 2.Example 2.
목단피 1kg을 완전 건조시킨 다음 50% 에탄올 20kg에 넣고 냉각 콘덴서가 달린 추출기에서 5시간 끓여서 추출한 후 400 메쉬 여과포로 여과하고 상온으로 냉각한 후 5-15℃에서 7일간 방치하여 숙성시킨 후 와트만 2번 여과지로 여과 하였다. 이 추출물을 냉각 콘덴서가 달린 증류장치에서 60℃로 감압 농축하여 102g(건조중량)을 얻었다.1kg of dried bark completely dried, and then placed in 20kg of 50% ethanol, extracted by boiling in an extractor equipped with a cooling condenser for 5 hours, filtered through a 400 mesh filter cloth, cooled to room temperature, left at 5-15 ° C for 7 days, and then aged. Once filtered with filter paper. The extract was concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser to obtain 102 g (dry weight).
실시예 3.Example 3.
목단피 1kg을 깨끗한 물로 씻어서 건조시킨다음 80% 에탄올 10ℓ에 넣고 냉각 콘덴서가 달린 추출기에서 5시간 끓여서 추출한 후 400 메쉬 여과포로 여과하고, 5-15℃에서 7일간 방치하여 숙성시킨 후 와트만 2번 여과지로 여과한다. 이 추출물을 냉각 콘덴서가 달린 증류장치에서 60℃로 감압 농축하여 98g(건조중량)을 얻었다.Wash 1 kg of dried bark with clean water, dry it, put it in 10 l of 80% ethanol, boil it for 5 hours in an extractor equipped with a cooling condenser, filter it with 400 mesh filter cloth, and leave it for 5 days at 5-15 ° C. for aging. Filter with. The extract was concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser to obtain 98 g (dry weight).
실시예 4.Example 4.
목단피 1kg을 깨끗한 물로 씻어서 건조시킨다음 에탄올 20ℓ에 넣고 냉각 콘덴서가 달린 추출기에서 5시간 끓여서 추출한 후 400 메쉬 여과포로 여과하고, 5-15℃에서 7일간 방치하여 숙성시킨 후 와트만 2번 여과지로 여과한다. 이 추출물을 냉각 콘덴서가 달린 증류장치에서 70℃로 감압 농축하여 122g(건조중량)을 얻었다.Wash 1kg of dried bark with clean water, dry it, put it in 20ℓ of ethanol, boil it for 5 hours in an extractor equipped with a cooling condenser, filter it with 400 mesh filter cloth, and leave it for 5 days at 5-15 ℃ for aging. do. The extract was concentrated under reduced pressure at 70 ° C. in a distillation apparatus equipped with a cooling condenser to obtain 122 g (dry weight).
실시예 5.Example 5.
목단피 1kg을 깨끗한 물로 씻어서 건조시킨다음 에탄올 20ℓ에 넣고 15-37℃에서 7일간 추출한 후 400 메쉬 여과포로 여과하고, 5-15℃에서 7일간 방치하여 숙성치킨 후 와트만 2번 여과지로 여과한다. 이 추출물을 냉각 콘덴서가 달린 증류장치에서 70℃로 감압 농축하여 118g(건조중량)을 얻었다.Wash 1kg of dried bark with clean water, dry it, put it in 20ℓ of ethanol, extract for 7 days at 15-37 ℃, filter it with 400 mesh filter cloth, leave it for 7 days at 5-15 ℃, and filter it with Whatman No. 2 filter paper. The extract was concentrated under reduced pressure at 70 ° C. in a distillation apparatus equipped with a cooling condenser to obtain 118 g (dry weight).
실시예 6-20.Example 6-20.
하기 표 1의 용매를 사용하고, 실시예5와 동일한 방법으로 추출하여 그 결과를 하기 표 1에 기재하였다.Using the solvent of Table 1 below, the extraction was carried out in the same manner as in Example 5, and the results are shown in Table 1 below.
표 1. 실시예 6-21의 실험결과Table 1. Experimental Results of Example 6-21
추출용매 최종 추출물의 건조중량Dry Weight of Extraction Solvent Final Extraction
(단위 : g )(Unit: g)
실시예6 50% 에탄올 100Example 6 50% Ethanol 100
실시예7 80% 에탄올 134Example 7 80% Ethanol 134
실시예8 메탄올 125Example 8 Methanol 125
실시예9 50% 메탄올 105Example 9 50% Methanol 105
실시예10 80% 메탄올 135Example 10 80% Methanol 135
실시예11 n-프로판올 120Example 11 n-propanol 120
실시예12 이소프로판올 101Example 12 Isopropanol 101
실시예13 n-부탄올 121Example 13 n-Butanol 121
실시예14 함수글리세린 76Example 14 Hydrated Glycerin 76
실시예15 함수프로필렌글리콜 86Example 15 Hydrous propylene glycol 86
실시예16 함수 부틸렌글리콜 99Example 16 Hydrated Butylene Glycol 99
실시예17 벤젠 54Example 17 Benzene 54
실시예18 클로로포름 42Example 18 Chloroform 42
실시예19 헥산 92Example 19 Hexane 92
실시예20 아세톤 88Example 20 Acetone 88
실시예21 정제수 111Example 21 Purified Water 111
처방예 1.Prescription Example 1.
목단피 추출물을 함유한 화장료중 유연 화장수(스킨)의 처방예는 다음과 같다. 목단피 추출물은 실시예 5에서 추출된 추출물을 사용하였다.Prescription example of flexible skin lotion (skin) in cosmetics containing extract of neck skin is as follows. As for the extract of neck bark, the extract extracted in Example 5 was used.
처방예 2.Prescription Example 2.
목단피 추출물을 함유한 화장료중 영양화장수(로숀)의 처방예는 다음과 같다. 목단피 추출물은 실시예 5에서 추출된 추출물을 사용하였다.A prescription example of nourishing cosmetics (loshon) in cosmetics containing extract of bark is as follows. As for the extract of neck bark, the extract extracted in Example 5 was used.
처방예 3.Prescription Example 3.
목단피 추출물을 함유한 화장료중 영양크림의 처방예는 다음과 같다.A prescription example of nourishing cream in cosmetics containing extract of neck peel is as follows.
목단피 추출물은 실시예 5에서 추출된 추출물을 사용하였다.As for the extract of neck bark, the extract extracted in Example 5 was used.
처방예 4.Prescription Example 4.
목단피 추출물을 함유한 화장료중 맛사지 크림의 처방예는 다음과 같다.A prescription example of a massage cream in cosmetics containing extract of neck skin is as follows.
목단피 추출물은 실시예 5에서 추출된 추출물을 사용하였다.As for the extract of neck bark, the extract extracted in Example 5 was used.
처방예 5.Prescription Example 5.
목단피 추출물을 함유한 화장료중 팩의 처방예는 다음과 같다.Prescription examples of packs of cosmetics containing the extract of neck skin are as follows.
목단피 추출물은 실시예 5에서 추출된 추출물을 사용하였다.As for the extract of neck bark, the extract extracted in Example 5 was used.
처방예 6.Prescription 6.
목단피 추출물을 함유한 화장료중 유화형 화운데이션의 처방예는 다음과 같다. 여기서 목단피 추출물은 실시예 5의 것을 말한다.Prescription examples of emulsified foundations in cosmetics containing the extract of neck skin are as follows. Here, the extract of neck skin refers to that of Example 5.
실험예 1.Experimental Example 1.
상기 실시예 1-21의 목단피 추출물에 대하여 항산화 효과를 측정 하였다.The antioxidant effect of the extract of Example 1-21 was determined.
1) 실험 방법1) Experiment Method
항산화 효과 측정은 펜톤반응(Fenton reaction)에 의한 지질과산화 반응계(lipid peroxidation system)을 이용한 티오부틸레이트아세트산(TBA) 시험으로 측정하였다. 에틸리놀레이트 10㎕, 0.02 % 도데실황산염, 염화제이철 10μ㏖, 과산화수소 2μ㏖을 함유하는 25mM 트리스 완충용액/ 0.75mM 칼륨 완충용액 5㎖에 목단피 추출물의 도데실메칠황산염 용액을 가한후 55℃에서 16시간 배양후, 4% 부틸히드록실톨루엔 50㎕를 가한후 반응을 정지시켰다. 다음 이 용액 0.3㎖을 시험관에 넣고 0.05몰 염산 3.0㎖, 0.67% 티오부틸레이트아세트산 용액을 가하고 30분간 끓였다. 이 반응액을 냉각 시킨후 85% 부탄올 4.0㎖을 가하고 원심 분리 후 부탄올 등의 흡광도를 535nm에서 측정하여 항산화 효과(%)를 구하였다. 이때 대조시험을 동시에 실시하였다.Antioxidant effect was measured by thiobutylate acetic acid (TBA) test using a lipid peroxidation system by the Fenton reaction. To 5 ml of 25 mM Tris buffer solution / 0.75 mM potassium buffer solution containing 10 µl of ethyl linoleate, 0.02% dodecyl sulfate, 10 µmol of ferric chloride, and 2 µmol of hydrogen peroxide, dodecylmethyl sulfate solution of the bark extract was added at 55 ° C. After 16 hours of incubation, 50 µl of 4% butylhydroxytoluene was added and the reaction was stopped. Next, 0.3 ml of this solution was put into a test tube, and 0.05 ml hydrochloric acid 3.0 ml and 0.67% thiobutylate acetic acid solution were added and the mixture was boiled for 30 minutes. After cooling the reaction solution, 4.0% of 85% butanol was added, and after centrifugation, the absorbance of butanol was measured at 535 nm to determine the antioxidant effect (%). At this time, the control test was performed simultaneously.
2)실험결과2) Experiment result
표 2. 목단피 추출물의 항산화 효과Table 2. Antioxidative Effects of Bark Extracts
실험예 2.Experimental Example 2.
상기 실시예 1-21의 목단피 추출물에 대하여 프리라디칼 소거 효과를 측정 하였다.Free radical scavenging effect was measured for the extract of the bark of Example 1-21.
1) 실험 방법1) Experiment Method
60μ㏖의 디펜닐피크릴히드라질(DPPH)용액 2㎖에 목단피 추출물의 도데실메칠황산염 용액을 가한후 37℃에서 30분간 반응 시킨후 520nm에서 흡광도를 측정하여 프리라디칼 소거작용(%)를 구했다. 이때 대조시험을 실시하였다.To 2 ml of 60 μmol of diphenylpicrylhydrazyl (DPPH) solution was added dodecyl methyl sulfate solution of the bark peel extract, reacted at 37 ° C. for 30 minutes, and the absorbance was measured at 520 nm to determine the free radical scavenging activity (%). At this time, a control test was performed.
2) 실험결과2) Experiment result
표 3. 목단피 추출물에 대한 프리라디칼 소거작용 효과Table 3. Effect of Free Radical Scavenging Effect on Bark Extracts
실험예 3.Experimental Example 3.
상기 실시예 1-21의 목단피 추출물에 대하여 엘라스타제 저해 효과를 측정 하였다.The elastase inhibitory effect was measured on the extract of the bark of Example 1-21.
1) 실험 방법1) Experiment Method
엘라스타제는 돼지 췌장으로부터 추출된 것으로 시그마(Sigma)사의 것을 사용 하였다. 췌장 엘라스타제에 의한 합성 팹티드 기질(Sigma)의 가수분해에 근거한 시험법으로 광파장 410㎚ 에서의 단위 시간당의 4-나트로아닐린의 방출량의 증가를 엘라스타제의 촉매 활성치로 하였다. 먼저 기질 용액을 1.0㎖씩 시험관에 넣고, 포타슘-포스페이트 완충용액과 증류수를 가한다. 각 추출물 시료로는 에탄올 용액에 적당농도로 함유시킨 0.2㎖의 추출물 시료액을 반응액에 넣은 뒤 37℃ 항온조에서 10분동안 반응 시킨다. 이때 대조군은 각 추출물 대신 용매만을 0.2㎖씩을 넣고 광전 분광 분석계로 파장 410㎚에서의 흡광도를 측정한다. 각 추출물의 엘라스타제 저해 효과는 다음의 공식으로 구한다.Elastase was extracted from porcine pancreas and used Sigma company. An increase in the amount of 4-natroaniline released per unit time at a light wavelength of 410 nm was determined as the catalytic activity of elastase by a test based on the hydrolysis of synthetic peptide substrate (Sigma) by pancreatic elastase. First, 1.0 ml of substrate solution is added to the test tube, and potassium-phosphate buffer solution and distilled water are added. For each extract sample, 0.2 ml of extract sample solution contained in an appropriate concentration in ethanol solution was added to the reaction solution and reacted for 10 minutes in a 37 ° C thermostat. In this case, only 0.2 ml of solvent was added instead of each extract, and the absorbance at the wavelength of 410 nm was measured by a photo spectrometer. The elastase inhibitory effect of each extract is obtained by the following formula.
엘라스타제 저해율(%) = [ 1 - ( 각 추출물의 효소 활성도/대조군의 효소 활성도) ] X 100% Elastase inhibition = [1-(enzyme activity of each extract / enzyme activity of control)] X 100
2) 실험결과2) Experiment result
표4. 목단피 추출물에 대한 엘라스타제 저해효과Table 4. Elastase Inhibitory Effects on Bark Extracts
실험예 4.Experimental Example 4.
상기 실시예 1-21 중에서 선택된 목단피 추출물에 대하여 히아루론라제 저해 효과를 측정 하였다.The hyaluronase inhibitory effect was measured on the extract of neck peel selected from Examples 1-21.
1) 실험 방법.1) Experimental method.
히아루론라제(시그마, 타입4)을 사용하여 콤파운드 48/80에 의한 불활성형 효소의 활성화 단계의 저해작용을 중심으로 측정했다. 목단피 추출물 시료를 0.1M 아세트산 완충용액( pH 4.0) 100㎖에 용해해서 시험관에 넣고, 아세트산 완충용액 50㎖에 용해한 효소 0.1mg을 가해 37도에서 20분간 방치시킨다. 최후로 아세트산 완충용액 250 ml에 녹인 히아루론산나트륨 200 mg을 가해 37도에서 40분간 방치시킨후 0.4 몰 수산화나트륨 100㎖를 가해 냉각후 붕소산 완충용액(pH 9.1) 100㎖을 가해 37℃에서 20분간 항온 시킨 후 585nm에서 흡광도를 측정한다. 대조로는 목단피 시료용액에 아세트산 완충용액을 사용한다. 대조 시험의 흡광도와 목단피 추출물 함유 흡광도의 비에서 100을 곱하여 저해효과를 ( % )로 나타내었다.Hyalurase (Sigma, Type 4) was used to measure the inhibitory activity of the activation step of the inactive enzyme by compound 48/80. Samples of the bark extract were dissolved in 100 ml of 0.1 M acetic acid buffer (pH 4.0), placed in a test tube, and 0.1 mg of the enzyme dissolved in 50 ml of acetic acid buffer was added and allowed to stand at 37 degrees for 20 minutes. Finally, 200 mg of sodium hyaluronate dissolved in 250 ml of acetic acid buffer was added and allowed to stand for 40 minutes at 37 ° C. After incubation, absorbance at 585 nm is measured. As a control, acetic acid buffer is used as the sample solution for neck skin. The inhibitory effect was expressed as (%) by multiplying 100 by the ratio of absorbance of the control test and absorbance containing the extract of Bark skin.
표 5. 목단피 추출물에 대한 히아루론라제 저해효과Table 5. Effect of Hyaluronase Inhibition on Bark Extracts
실험예 5.Experimental Example 5.
상기 실시예 1-21 중에서 선택된 목단피 추출물에 대하여 세포의 멜라닌 생성 억제 작용으로 미백 효과를 측정 하였다.The whitening effect was measured by the melanin production inhibitory effect of the cells on the extract selected from Example 1-21.
1) 실험 방법.1) Experimental method.
멜라노사이트 배양을 통하여 멜라닌 생성 억제 기능을 세포 수준에서 검정 하였다. B16 멜라노마 세포는 10% 소의 멜라노마 세포를 5% 이산화탄소가 존재하는 곳에서 2일간 배양하여 1.0X108세포/T25프라스크가 될 때까지 배양하였다. 그 후, 배양중간체를 제거하고 트립신을 첨가하여 세포들을 원심분리하여 수거하여 세포의 흑화 정도를 관측하였다. 세포에 존재하는 멜라닌의 정량은 수건된 세포를 5% 트리클로로로아세트산를 이용하여 세포를 세척한 후, 에테르-에탄올 용액과 에테르를 처리하여 세포를 세척한 다음, 1 몰 수산화나트륨를 처리하여 90도에서 멜라닌들을 용액 속으로 녹여냈다. 475 nm에서 용액 속의 멜라닌을 정량하고 세포수를 세어 단위 세포당 생성된 멜라닌의 양을 정량하여 %로 저해 효과를 나타냈다.Melanin production inhibition function was assayed at the cellular level through melanocyte culture. B16 melanoma cells were incubated for 10 days in 10% bovine melanoma cells in the presence of 5% carbon dioxide until 1.0X108 cells / T25 flask. Thereafter, the culture medium was removed and the cells were collected by centrifugation with trypsin added to observe the degree of blackening of the cells. Determination of melanin present in the cells was performed by washing the cells with 5% trichloroacetic acid in the toweled cells, washing the cells with ether-ethanol solution and ether, and then treating them with 1 mol sodium hydroxide at 90 ° C. Melanin was dissolved into solution. The melanin in the solution was quantified at 475 nm and the number of cells was counted to quantify the amount of melanin produced per unit cell.
2)실험결과2) Experiment result
표 6. 목단피 추출물에 대한 미백효과 측정 결과Table 6. Measurement of Whitening Effect on Bark Extracts
실험예 6.Experimental Example 6.
상기 실시예 1-21 중에서 선택된 목단피 추출물에 대하여 피부 탄력성에 대한 증진 효과를 측정 하였다.Enhancement effect on skin elasticity was measured for the extract of neck skin selected from Example 1-21.
1) 실험방법1) Experiment Method
피부탄력성에 대한 목단피 추출물의 영향을 실험하기 위해 20명의 왼쪽눈 가장자리에 하루에 두번 적용하였다. 처리하지 않은 오른쪽 눈 가장자리는 대조군으로 사용하였다. 목단피 추출물 함유 화장료를 처리하기 전과 처리하고난 14일 후 피부 표면의 피부 탄력성을 Corneometer CM 820과 Cutometer SEM 474에 의해 측정 하였다. Corneometer CM 820에 의한 피부 보습 측정은 대조군에 비해 증가한 보습력 값을 %로 나타내었으며, 피검자 20명의 평균값을 결과에 나타내었다. Cutometer SEM 474에 의한 피부 탄력도 측정은 주름의 깊이를 측정하는 것으로서, 값이 적을수록 탄력성이 좋은 것이다. 탄력도 값은 대조군에 비해 감소한 값을 %로 나타내었으며, 피검자 20명의 평균값을 하기 표 7에 나타내었다.To examine the effect of the extract of bark on skin elasticity, it was applied twice a day to the edge of the left eye of 20 people. Untreated right eye edge was used as a control. The skin elasticity of the skin surface was measured by Corneometer CM 820 and Cutometer SEM 474 before and after treatment with the cosmetic extract containing the extract of the neck peel. Skin moisture measurement by Corneometer CM 820 showed the increased moisturizing value in% compared to the control group and the average value of 20 subjects was shown in the results. Skin elasticity measurement by Cutometer SEM 474 is a measure of the depth of wrinkles, the smaller the value is the better elasticity. The elasticity value was expressed as a percentage decrease compared to the control, and the average value of 20 subjects is shown in Table 7 below.
2) 실험 결과2) Experiment result
표 7. 목단피 추출물의 피부 표면 보습 및 탄력도 증가 효과Table 7. Moisturizing and Elasticity-Increasing Effects of Bark Extracts
본 발명의 목단피 추출물을 상기 실험예의 결과에서 에서 알 수 있듯이 우수한 프리라디칼 소거작용, 항산화작용 및 미백효과를 갖는다. 따라서, 본 발명의 목단피 추출물을 함유하는 화장료 조성물은 노화방지 및 피부 미백 및 피부 탄력 증진에 효과적이다.The bark extract of the present invention has excellent free radical scavenging, antioxidant and whitening effects as can be seen from the results of the above experimental example. Therefore, the cosmetic composition containing the extract of the bark of the present invention is effective in anti-aging and skin whitening and skin elasticity enhancement.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990014768A KR20000067187A (en) | 1999-04-24 | 1999-04-24 | Cosmetics containing Paeonia Suffruticosa Andrews extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990014768A KR20000067187A (en) | 1999-04-24 | 1999-04-24 | Cosmetics containing Paeonia Suffruticosa Andrews extracts |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20000067187A true KR20000067187A (en) | 2000-11-15 |
Family
ID=19582085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990014768A KR20000067187A (en) | 1999-04-24 | 1999-04-24 | Cosmetics containing Paeonia Suffruticosa Andrews extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20000067187A (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010088120A (en) * | 2000-03-10 | 2001-09-26 | 손 경 식 | Whitening Cosmetics Composition containing Mixed Extracts of Plants |
KR20020094349A (en) * | 2001-06-11 | 2002-12-18 | 주식회사 코리아나화장품 | Cosmetics containing a mixture of Moutan radicis cortex extracts, Ramulus mori extracts and Saxifraga stolonifera extracts for skin whitening |
KR100443588B1 (en) * | 2002-01-25 | 2004-08-09 | 나드리화장품주식회사 | Cosmetic composition containing paeonia suffruticosa andrews extract and albizzia julibrissin dura extract having anti-ageing effect |
KR100882744B1 (en) * | 2008-11-05 | 2009-02-23 | (주)더페이스샵코리아 | Manufacturing method of cosmetic composition containing extract |
WO2013012118A1 (en) * | 2011-07-20 | 2013-01-24 | Sinil Pharmaceutical Co., Ltd. | Novel phenylester compound and pharmaceutical compositions for preventing or treating inflammatory diseases comprising the same |
CN112438915A (en) * | 2019-08-28 | 2021-03-05 | 广州市南方医康生物科技有限公司 | Skin care composition, cosmetic and preparation method thereof |
KR102368302B1 (en) | 2021-12-23 | 2022-03-02 | 한솔생명과학(주) | Cosmetic composition for improvement skin inflammation containing tree spikemoss and moutan cortex extract |
-
1999
- 1999-04-24 KR KR1019990014768A patent/KR20000067187A/en not_active Application Discontinuation
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010088120A (en) * | 2000-03-10 | 2001-09-26 | 손 경 식 | Whitening Cosmetics Composition containing Mixed Extracts of Plants |
KR20020094349A (en) * | 2001-06-11 | 2002-12-18 | 주식회사 코리아나화장품 | Cosmetics containing a mixture of Moutan radicis cortex extracts, Ramulus mori extracts and Saxifraga stolonifera extracts for skin whitening |
KR100443588B1 (en) * | 2002-01-25 | 2004-08-09 | 나드리화장품주식회사 | Cosmetic composition containing paeonia suffruticosa andrews extract and albizzia julibrissin dura extract having anti-ageing effect |
KR100882744B1 (en) * | 2008-11-05 | 2009-02-23 | (주)더페이스샵코리아 | Manufacturing method of cosmetic composition containing extract |
WO2013012118A1 (en) * | 2011-07-20 | 2013-01-24 | Sinil Pharmaceutical Co., Ltd. | Novel phenylester compound and pharmaceutical compositions for preventing or treating inflammatory diseases comprising the same |
CN112438915A (en) * | 2019-08-28 | 2021-03-05 | 广州市南方医康生物科技有限公司 | Skin care composition, cosmetic and preparation method thereof |
CN112438915B (en) * | 2019-08-28 | 2023-05-05 | 广州市南方医康生物科技有限公司 | Skin care composition, cosmetic and method for producing same |
KR102368302B1 (en) | 2021-12-23 | 2022-03-02 | 한솔생명과학(주) | Cosmetic composition for improvement skin inflammation containing tree spikemoss and moutan cortex extract |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20240000699A1 (en) | Cosmetic composition comprising lycium chinense mill fermentation extract and green tea fermentation extract, and method for manufacturing same | |
KR100422419B1 (en) | Whitening cosmetic composition containing herb extracts | |
JP2003081749A (en) | Skin care preparation | |
KR20000067187A (en) | Cosmetics containing Paeonia Suffruticosa Andrews extracts | |
KR100295875B1 (en) | Cosmetics Containing Green Bean Extract | |
KR100350083B1 (en) | Compositions for whitening cosmetics | |
KR20130040316A (en) | Cosmetics composites | |
KR100338684B1 (en) | The extracting method of sericin and use thereof | |
KR100864915B1 (en) | Composition containing as an active ingredient plum and catabolic extract with antioxidant | |
KR101458758B1 (en) | Garlic extract with the effect of skin whithening and anti-oxient, manufacturing method htereof and cosmetic composition comprising the same | |
KR100589484B1 (en) | Cosmetics Containing Situation Mushroom Extract | |
KR101614500B1 (en) | a cosmetic Composition and the manufacturing Method thereof | |
KR20020093251A (en) | A cosmetic composition containing mixing extract of shipjangsaeng-related natural substance(Pinus sylvestris, Ganoderma lucidum Karst., Arbutin, Cervus elaphus L., Amyda sinensis, Germanum, Apis mellifera L., Panax ginseng C. A. Meyer, salmon egg, Citrus Medica Limonum) | |
KR101413643B1 (en) | Cosmetics containing Eurycoma longifolia jack extracts and method manufacturing the same | |
KR20010018665A (en) | A cosmetic composition containing Bambusae caulis in Taenian extracts | |
KR100642681B1 (en) | Bio Placenta skin coating composition containing placenta extract and its manufacturing method | |
KR100472122B1 (en) | Anti-aging cosmetics composition containing Phenolic compound | |
KR101176525B1 (en) | Cosmetic Composition Comprising Acer tegmentosum Maxim as Active Ingredient | |
KR20010018668A (en) | A cosmetic composition containing Cinnamomi Cortex extracts | |
KR102722292B1 (en) | Compositions containing Orostachydis Herba extract | |
KR20010055960A (en) | Skin care composition containing Cinnamomum cassia extract | |
KR20200046674A (en) | A composition for antioxidating, whitening and improving wrinkle comprising extracts of black persimmon | |
KR102706480B1 (en) | Composition comprising Sasa quelpaertensis fermented extract and green tea fermented extract and various uses thereof | |
KR20010058419A (en) | Cosmetics containing Areca catechu L. for removing free radical | |
KR20010018663A (en) | A cosmetic composition containing Terminaliae Fructus extracts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19990424 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20001229 Patent event code: PE09021S01D |
|
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20010821 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20001229 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
J201 | Request for trial against refusal decision | ||
PJ0201 | Trial against decision of rejection |
Patent event date: 20010921 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20010821 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20011004 Appeal identifier: 2001101003137 Request date: 20010921 |
|
J121 | Written withdrawal of request for trial | ||
PJ1201 | Withdrawal of trial |
Patent event code: PJ12011R01D Patent event date: 20011004 Comment text: Written Withdrawal of Request for Trial Appeal identifier: 2001101003137 Request date: 20010921 Appeal kind category: Appeal against decision to decline refusal Decision date: 20011004 |